Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I.
Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I.
复制标题
DOI:
10.1016/j.redox.2015.01.005
复制
发表时间:
2015
期刊:
影响因子:
11.4
通讯作者:
Boelsterli, Urs A.
中科院分区:
文献类型:
--
作者:
Imaizumi, Naoki;Lee, Kang Kwang;Zhang, Carmen;Boelsterli, Urs A.
Respiratory complex I inhibition by drugs and other chemicals has been implicated as a frequent mode of mitochondria-mediated cell injury. However, the exact mechanisms leading to the activation of cell death pathways are incompletely understood. This study was designed to explore the relative contributions to cell injury of three distinct consequences of complex I inhibition, i.e., impairment of ATP biosynthesis, increased formation of superoxide and, hence, peroxynitrite, and inhibition of the mitochondrial protein deacetylase, Sirt3, due to imbalance of the NADH/NAD+ ratio. We used the antiviral drug efavirenz (EFV) to model drug-induced complex I inhibition. Exposure of cultured mouse hepatocytes to EFV resulted in a rapid onset of cell injury, featuring a no-effect level at 30 µM EFV and submaximal effects at 50 µM EFV. EFV caused a concentration-dependent decrease in cellular ATP levels. Furthermore, EFV resulted in increased formation of peroxynitrite and oxidation of mitochondrial protein thiols, including cyclophilin D (CypD). This was prevented by the superoxide scavenger, Fe-TCP, or the peroxynitrite decomposition catalyst, Fe-TMPyP. Both ferroporphyrins completely protected from EFV-induced cell injury, suggesting that peroxynitrite contributed to the cell injury. Finally, EFV increased the NADH/NAD+ ratio, inhibited Sirt3 activity, and led to hyperacetylated lysine residues, including those in CypD. However, hepatocytes isolated from Sirt3-null mice were protected against 40 µM EFV as compared to their wild-type controls. In conclusion, these data are compatible with the concept that chemical inhibition of complex I activates multiple pathways leading to cell injury; among these, peroxynitrite formation may be the most critical. The antiviral drug efavirenz (EFV) induces complex I inhibition. Complex I inhibition causes ATP depletion, ROS/RNS formation, and Sirt3 inhibition. Iron porphyrins protect hepatocytes against EFV-induced lethal injury. Genetic ablation of Sirt3 (Sirt3−/− mice) protects against EFV toxicity. Peroxynitrite formation is a major mechanism of mitochondria-mediated cell injury.
登录
查看更多内容
影响因子:
4.8
作者:
Davey, GP;Peuchen, S;Clark, JB
通讯作者:
Clark, JB
影响因子:
3.4
作者:
Burger, D;van der Heiden, I;van Schaik, R
通讯作者:
van Schaik, R
影响因子:
7.7
作者:
Lu, Zhongping;Bourdi, Mohammed;Sack, Michael N.
通讯作者:
Sack, Michael N.
DOI:
10.1073/pnas.0508215102
发表时间:
2005-12-27
影响因子:
11.1
作者:
Perier, C;Tieu, K;Vila, M
通讯作者:
Vila, M
影响因子:
4.3
作者:
Chan, Katie;Truong, Don;O'Brien, Peter J
通讯作者:
O'Brien, Peter J